Genentech, part of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), is making headway in the race to develop new treatments for multiple sclerosis (MS)....
Multiple Sclerosis
Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company focused on developing innovative solutions for neurodegenerative and metabolic disorders, has announced a collaborative clinical study with...
